{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:20:03Z","timestamp":1789154403302,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>This case report describes a 37-year-old man who underwent renal transplantation and subsequently developed complicated recurrent urinary tract infections (UTIs) caused by multidrug-resistant (MDR) <jats:italic>Klebsiella pneumoniae<\/jats:italic>. Despite initial treatment with fosfomycin and meropenem, the patient experienced persistent UTIs, leading to multiple hospitalizations. The management of these recurrent infections eventually required the use of tigecycline. Although tigecycline is not typically considered a urinary antibiotic owing to its limited urinary excretion, it was successfully employed in this case to manage the recurrent infections. The patient was treated with tigecycline for several episodes of UTI, which provided a crucial therapeutic option in the context of antibiotic resistance. This case underscores the challenges of managing recurrent MDR UTIs in immunocompromised patients and highlights tigecycline as an effective treatment strategy when standard therapies fail.<\/jats:p>","DOI":"10.3389\/frtra.2024.1496702","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:54:32Z","timestamp":1739861672000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Management of recurrent UTI with tigecycline in a kidney transplant recipient"],"prefix":"10.3389","volume":"3","author":[{"given":"Supreeta R.","family":"Shettar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadevaiah Neelambike","family":"Sumana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath S.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogeesh D.","family":"Maheshwarappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghukanth G.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshi Dharan","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Kalyatanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi Shree","family":"S C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"861374","DOI":"10.3389\/fcimb.2022.861374","article-title":"Urinary tract infections caused by K. pneumoniae in kidney transplant recipients\u2014epidemiology, virulence and antibiotic resistance","volume":"12","author":"Krawczyk","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e13507","DOI":"10.1111\/ctr.13507","article-title":"Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Goldman","year":"2019","journal-title":"Clin Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1365-2362.2008.02014.x","article-title":"Urinary tract infection in renal transplant recipients","volume":"38","author":"S\u00e4emann","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.transproceed.2006.08.018","article-title":"Epidemiology of urinary infections in renal transplant recipients","volume":"38","author":"Valera","year":"2006","journal-title":"Transplant Proc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/genes12081285","article-title":"Genetic background and antibiotic resistance profiles of K. pneumoniae NDM-1 strains isolated from UTI, ABU, and the GI tract, from one hospital in Poland, in relation to strains nationally and worldwide","volume":"12","author":"Wysocka","year":"2021","journal-title":"Genes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10096-021-04388-y","article-title":"Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report","volume":"41","author":"Arcari","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","article-title":"Klebsiella pneumoniae: going on the offense with a strong defense","volume":"80","author":"Paczosa","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e57647","DOI":"10.5812\/jjm.57647","article-title":"Successful treatment of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae recurrent urinary tract infection with high doses of amoxicillin with clavulanic acid in a kidney transplant recipients: a case report","volume":"10","author":"Wilkowski","year":"2017","journal-title":"Jundishapur J Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3892\/etm.2021.10520","article-title":"Insights into multidrug-resistant K. pneumoniae urinary tract infections: from susceptibility to mortality","volume":"22","author":"Miftode","year":"2021","journal-title":"Exp Ther Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.eimc.2017.10.019","article-title":"Executive summary: diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Society of Intensive Care Medicine and Coronary Units (SEMICYUC)","volume":"36","author":"Chaves","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","article-title":"Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America","volume":"68","author":"Nicolle","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B12","article-title":"Asymptomatic Bacteriuria","author":"Givler","year":""},{"key":"B13","article-title":"Indian Council for Medical Research (ICMR). Treatment guidelines for antimicrobial use in common syndromes","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"ofaa034","DOI":"10.1093\/ofid\/ofaa034","article-title":"Multiple-dose oral fosfomycin for treatment of complicated urinary tract infections in the outpatient setting","volume":"7","author":"Derington","year":"2020","journal-title":"InOpen Forum Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/2051415820930625","article-title":"Tigecycline: a rescue drug for multi-drug-resistant organisms causing urinary tract infection","volume":"16","author":"Bhatt","year":"2023","journal-title":"J Clin Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.53854\/liim-3004-5","article-title":"Role of tigecycline in treating urinary tract infections: a systematic review of published case reports","volume":"30","author":"Charles","year":"2022","journal-title":"Infez Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2147\/IDR.S402275","article-title":"A simple disk stacking plus micro-elution method for rapid detection of the synergistic effect of aztreonam and ceftazidime\/avibactam against metallo-\u03b2-lactamase producing Enterobacterales","volume":"16","author":"Liu","year":"2023","journal-title":"Infect Drug Resist"},{"key":"B18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"B19","first-page":"478","article-title":"Profilul de rezisten\u0163\u0103 al E. coli si Klebsiella spp. din infec\u0163ii urinare in Spitalul de Boli Infec\u0163ioase Ia\u015fi [Antimicrobial resistance profile of E. coli and Klebsiella spp. from urine in the Infectious Diseases Hospital Ia\u015fi]","volume":"112","author":"Miftode","year":"2008","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s10096-020-04121-1","article-title":"Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review","volume":"41","author":"Yaghoubi","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","article-title":"Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents","volume":"132","author":"Bader","year":"2020","journal-title":"Postgrad Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e65617","DOI":"10.7759\/cureus.65617","article-title":"Tigecycline-based regimens for complicated urinary tract infections caused by carbapenem-resistant gram-negative bacteria: case series","volume":"16","author":"Niculae","year":"2024","journal-title":"Cureus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/jac\/dkq224","article-title":"Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"65","author":"Geerlings","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/jac\/dkn165","article-title":"Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) acinetobacter infections: a review of the scientific evidence","volume":"62","author":"Karageorgopoulos","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/jac\/dki291","article-title":"Tigecycline: what is it, and where should it be used?","volume":"56","author":"Livermore","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/8755122513519332","article-title":"Role of tigecycline for the treatment of urinary tract infections","volume":"30","author":"Wu","year":"2014","journal-title":"J Pharm Technol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"29299","DOI":"10.21037\/tau-20-959","article-title":"Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review","volume":"10","author":"Liu","year":"2021","journal-title":"Transl Androl Urol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4212\/cjhp.v65i3.1144","article-title":"Tigecycline treatment of urinary tract infection and prostatitis: case report and literature review","volume":"65","author":"Bates","year":"2012","journal-title":"Can J Hosp Pharm"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2024.1496702\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:54:36Z","timestamp":1739861676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2024.1496702\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":28,"alternative-id":["10.3389\/frtra.2024.1496702"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2024.1496702","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"article-number":"1496702"}}